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Gonococcal pili were initially purified in 1972 (1) . Studies with a fluorescein-
conjugated globulin fraction of rabbit antiserum to purified gonococcal pili of
strain 2686 suggested common antigenicity among gonococcal pili of 18 strains
tested from the New York City area (2) . Further evidence of shared antigens on
many gonococcal pili was obtained with a radioactive antigen-binding assay
using 'III-labeled purified gonococcal pili of strain 2686 . This assay detected
elevated antibody levels to 2686 pili in serum from 60 to 80% of patients with
gonococcal infection (2, 3) and in serum from each of two groups of chimpanzees
immunized with distinctly different strains of gonococci (4) . However, no studies
have been reported that directly compare purified pili from different strains of
gonococci .
The development of a new purification procedure reported herein has allowed
production of purified pili from two different gonococcal strains (2686 and 33),
and direct comparison of their antigenicity in an antigen-binding assay . These
studies indicate that pili of strains 2686 and 33 are distinguishable antigenically .
Materials and Methods
Strains of Neisseria gonorrhoeae .
￿
Two strains of gonococci were used ; 2686 from Dr . Douglas
Kellogg, Center for Disease Control, Atlanta, Ga . (2) and 33 from Dr . Kenneth Johnston, The
Rockefeller University, New York . These two strains were of different gonococcal serotypes as tested
and described by Johnston and Gotschlich (5) . Different serotypes of gonococci were picked to insure
that the gonococcal strains studied were distinctly different, since previous studies indicated
antigenic similarity of pili from many gonococci (2, 3) .
Purification of Gonococcal Pili . Colony type 2 gonococci were grown in liquid culture as
previously described (2, 6) . At the height of log phase growth, the liquid culture was briefly sheared in
an omnimixer (Dupont Instruments, Sorval Operations, Newtown, Conn .) . Organisms and large
debris were removedfrom the sheared culture by centrifugation at 30,000 gfor30 min. Thesupernate
was centrifuged at 150,000g for 12-16 h. The pellet was resuspended in 0.01M Tris buffer, pH 7.5,
0.01 M sodium azide, and centrifuged at 12,000 g. The supernate was mixed well with an equal
volume of 20% saturated ammonium sulphate and left at 4°C overnight . The ammonium sulphate
suspension was centrifuged at 30,000 g for 10 min and the precipitate was washed once in 10%
saturated ammonium sulphate . After recentrifugation, the washed precipitate was redissolved in
distilled water . The ammonium sulphate precipitation, washing, and centrifugation steps were
repeated once and the precipitate was dissolved in distilled water so as to concentrate the original
liquid culture 250- to 500-fold .
Criteria for Purity of Gonococcal Pili .
￿
Direct observation by electron microscopy and sodium
dodecyl sulfate (SDS) polyacrylamide disc gel electrophoresis were used to assess the purity of
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gonococcal pili preparations from strains 2686 and 33 as previously described (2) . Gels containing
unlabeled samples were fixed and the SDS bleached out using 5.0%TCA . They were then stained
using 0.025% aqueous Coomassie Brilliant Blue (Sigma Chemical Co ., St . Louis, Mo .) in 7% acetic
acid containing 45% methanol for 5-8 h, and destained in 7% acetic acid containing 10% methanol .
Slab gels were run according to the techniques of Maizel (7) to simultaneously compare pili from
strains 33 and 2686 . After initial experiments showed that a single band of protein staining with
Coomassie Blue was obtained which corresponded to the single peak of radioactivity for the
radioactive pili samples, pili preparations were routinely assessed with radioactive samples so as to
conserve pili . Pili preparations were labeled with 12sí by the chloramine-T procedure ofGreenwood et
al . (8) .
Radioimmunoassay for Gonococcal Pili .
￿
The radioimmunoassay utilized for gonococcal pili was
as described previously (2) . Approximately 100 ng of 1251 labeled purified gonococcal pili from strain
2686 or 33 was reacted with a quantity of antiserum that contained approximately 2 ng of
IgG-precipitating rabbit antibody to pili of strain 2686 or 33, respectively . This amount of antibody
produced approximately 65% binding of the radiolabeled pili . To this constant amount of
radiolabeled pili and antiserum in a series of microfuge tubes, was added incremental amounts of
purified pili from either thesame or a different gonococcal strain . Only pili that were pure by electron
microscopy (Fig . 1) and SDS polyacrylamide gel electrophoresis were used in these studies . The
radioisotope "Nawasadded as avolume marker and the finalvolumes were equalized with 1% bovine
serum albumin in phosphate-buffered saline, pH 7 .2 . After mixing well, the suspensions of antigen,
antibody, and inhibitor were allowed to equilibrate overnight at 4°C. After equilibration, all
antibodies in the rabbit antiserum were precipitated with goat antirabbit immunoglobulin
antiserum . The percent binding of 12Sí-labeled pili antigen was determined after centrifugation,
removal of supernate, and assessment of radioactivity in the precipitate as previously reported (2, 9) .
The inhibition of binding of the radiolabeled pili was calculated using the formula :
%I= 100
￿
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Purified gonococcal pili from strain 2686 (x 125,000) . Pili from strains 33 and 2686
were morphologically indistinguishable . White dots are a grid-stain artifact .1472
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where I, inhibition ; B., binding without inhibitor ; andB ;, binding in the presence of inhibitor . The
protein concentration of purified pili preparations was determined using the Folin-Ciocalteu method
as described by Lowry et al ., using bovine plasma albumin (Metrix, Armour Pharmaceutical Co .,
Chicago, Ill.) as astandard (10) .
Results
Purified gonococcal pili from strains 2686 and 33 were obtained in yields of
50-100 gg/liter of liquid culture using the purification procedure based on
precipitation of gonococcal pili in 10% saturated ammonium sulphate . The SDS
polyacrylamide gel electrophoresis patterns obtained for purified pili prepara-
tions from strains 2686 and 33 used in these studies are shown in Figs . 2 and 3,
respectively . When these two pili preparations were electrophoresed in the same
slab SDS polyacrylamide gel their subunit molecular weights were identical . Fig .
4 compares the inhibiting ability of purified gonococcal pili of strains 2868 and33
in a binding system utilizing 12'I-labeled 2686 pili and antibody to 2686 pili .
Nonlabeled pili from strain 2686 progressively inhibited the assay with incre-
ments of 320-3,200 ng of pili . In contrast, no significant inhibition of the assay
was produced with equal amounts of purified pili from strain 33 (Fig . 4) . Fig. 5
compares the inhibiting ability of purified gonococcal pili of strains 2686 and 33
for an immunoassay utilizing '25I-labeled pili from strain 33 and antibody to
strain 33 pili . Porgressive inhibition ofbinding of labeled pili from strain 33 was
produced with 50- to 2,500-ng increments of nonlabeled purified pili from the
same strain (Fig . 5) . Purified pili from strain 2686 failed to produce significant
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￿
SDS 10% polyacrylamide gel pattern of I'll-labeled purified pili from strain 2686 .
FIG. 3.
￿
SDS 10% polyacrylamide gel pattern of 'III-labeled purified pili from strain 33 .
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FIG. 4 . Pili radioimmunoassay with 12'1-labeled 2686 pili and antiserum to 2686 pili .
Inhibition with purified pili from strains 2686 and 33 .
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FIG. 5. Pili radioimmunoassay with "5I-labeled 33 pili and antiserum to 33 pili . Inhibition
with purified pili from strains 33 and 2686 .
inhibition of this assay even in amounts as great as 6,400 ng, a64-foldexcess over
the amount of labeled strain 33 pili .
Discussion
These results indicate that the pili of strains 2686 and 33 are antigenically
different . Some common antigens may be present on the two pili types as
indicated by nearly maximal binding of labeled pili preparations by high titered
antiserum to pili of either strain 2686 or 33 . However, most of the antigenic sites
on pili strain 2686 appear different from those on strain 33 pili when compared on
a weight basis as illustrated in Figs . 4 and 5 . This type of radioimmunoassay
analysis allows clear differentiation of the two pili types .
The recognition that gonococcal pili vary antigenically between some strains
may facilitate studies to determine the genetic control of piliation in gonococci .
For example, transformation of strain 33 to produce pili of strain 2686 by DNA
from strain 2686 could be detected by radioimmunoassay evaluation of the pili1474
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produced by the transformed gonococci . Further antigenic types of gonococcal
pili are likely to exist and serologic typing of gonococci based on different
antigenic types of gonococcal pili may prove useful as an epidemiologic marker .
Since gonococcal pili are sufficiently pure to be used as a radiolabeled antigen in
antigen-binding assays, it may also be possible to determine the specific
antigenic type of pili produced by gonococci infecting a given patient by
quantitating the patient's antibody response to each separate gonococcal pili
type . Antigenic types of pili produced by gonococci may differ by geographic area
and with regard to clinical syndromes of gonococcal infection . The sensitivity of
tests to detect antibody to pili in patients with gonorrhea may be increased by
including more than one antigenic type of gonococcal pili within the antigen
preparations .
Summary
Pili were isolated from two different strains of gonococci (33 and 2686) and
demonstrated to be pure by the criteria of electron microscopy and polyacrylam-
ide gel electrophoresis in sodium dodecyl sulfate . Each purified pili preparation
was studied for its ability to inhibit ; (a) binding of '251-labeled purified 2686 pili
by antibody to 2686 pili, and (b) binding of 1251-labeled purified 33 pili by
antibody to 33 pili . In each instance progressive inhibition of binding was
produced by the homologous pili type, but no significant inhibition was observed
using comparable weights of the heterologous pili type . These results indicate
that the pili of strains 2686 and 33 are antigenically different .
The author thanks Wendy Ngo for valuable technical assistance, Dr . GaryK. Schoolnik forpreparing
the rabbit antiserum to gonococci of strain 33, and Dr . King K. Holmes for his advice and
encouragement with the manuscript . The improved purification procedure for gonococcal pili
mentioned in this article was developed in collaboration with Larry Loomis and Larry Warfel of
BioQuest Div., Becton, Dickinson & Co ., Cockeysville, Md ., and Dr . Emil C. Gotschlich, The
Rockefeller University, New York .'
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